Literature DB >> 9508430

Microplate assays for in vitro evaluation of anti-Pneumocystis drugs.

E Herreros1, M J Almela, M Martinez, S Lozano, H Jackson, E M Aliouat, D Gargallo-Viola.   

Abstract

Mesh：

Substances：

Year:  1997        PMID： 9508430     DOI： 10.1111/j.1550-7408.1997.tb05766.x

Source DB:  PubMed          Journal:  J Eukaryot Microbiol        ISSN： 1066-5234            Impact factor:   3.346


× No keyword cloud information.
  4 in total

1.  In vitro pharmacodynamic parameters of sordarin derivatives in comparison with those of marketed compounds against Pneumocystis carinii isolated from rats.

Authors:  P Aviles; E M Aliouat; A Martinez; E Dei-Cas; E Herreros; L Dujardin; D Gargallo-Viola
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

2.  Antifungal activities and cytotoxicity studies of six new azasordarins.

Authors:  E Herreros; M J Almela; S Lozano; F Gomez de las Heras; D Gargallo-Viola
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

3.  Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi.

Authors:  E Herreros; C M Martinez; M J Almela; M S Marriott; F G De Las Heras; D Gargallo-Viola
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

4.  SYTO-13, a Viability Marker as a New Tool to Monitor In Vitro Pharmacodynamic Parameters of Anti-Pneumocystis Drugs.

Authors:  Annie Standaert-Vitse; Cécile-Marie Aliouat-Denis; Anna Martinez; Sara Khalife; Muriel Pottier; Nausicaa Gantois; Eduardo Dei-Cas; El Moukhtar Aliouat
Journal:  PLoS One       Date:  2015-06-23       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.